Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosisSimon Thebault, Mark S. Freedman, Ronald A. Booth et al.|Annals of Clinical and Translational Neurology|2020Cited by 34
Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosisGauruv Bose, Mark S. Freedman, Harold Atkins et al.|Multiple Sclerosis Journal|2018Cited by 31
A real-world single-centre analysis of alemtuzumab and cladribine for multiple sclerosisGauruv Bose, Mark S. Freedman, Carolina Rush et al.|Multiple Sclerosis and Related Disorders|2021Cited by 30
Autologous hematopoietic stem cell transplantation for multiple sclerosis: A current perspectiveGauruv Bose, Mark S. Freedman, Simon Thebault et al.|Multiple Sclerosis Journal|2020Cited by 14
Does Resetting the Immune System Fix Multiple Sclerosis?Gauruv Bose, Mark S. Freedman, Simon Thebault et al.|Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques|2019Cited by 11